Mapping the genome of Plasmodium falciparum on the drug-like chemical space reveals novel anti-malarial targets and potential drug leads

Autor: Irene Kouskoumvekaki, Damian R. Plichta, Kasper P. Jensen, Gianni Panagiotou
Rok vydání: 2012
Předmět:
60504
Parasitology - Medical

Druggability
10060
Biochemistry studies - General

Drug resistance
Protozoa Invertebrata Animalia (Animals
Invertebrates
Microorganisms
Protozoans) - Sporozoa [35400] Plasmodium falciparum species parasite strain-D2d

Chemical library
growth inhibition
comparative
experimental morphology
physiology and pathology - Protozoa [64002
Invertebrata]

chemistry.chemical_compound
Drug Discovery
Cluster Analysis
15002
Blood - Blood and lymph studies

polypharmacology profile
cancer Neoplasms (MeSH) neoplastic disease
Chromosome Mapping
Genomics
15006
Blood - Blood
lymphatic and reticuloendothelial pathologies

60502
Parasitology - General

15004
Blood - Blood cell studies

Proteome
multi-drug resistance
Biotechnology
neurological disorder nervous system disease
Plasmodium falciparum
Computational biology
Biology
Small Molecule Libraries
proteins drug target
Antimalarials
SDG 3 - Good Health and Well-being
Transport and Circulation
metabolic network
parasitic diseases
medicine
10062
Biochemistry studies - Nucleic acids
purines and pyrimidines

genome
Molecular Biology
18506
Integumentary system - Pathology

10064
Biochemistry studies - Proteins
peptides and amino acids

Biochemistry and Molecular Biophysics
dermatological disorder integumentary system disease
medicine.disease
biology.organism_classification
24004
Neoplasms - Pathology
clinical aspects and systemic effects

Chemical space
20506
Nervous system - Pathology

Parasitology
chemistry
Primates Mammalia Vertebrata Chordata Animalia (Animals
Chordates
Humans
Mammals
Primates
Vertebrates) - Hominidae [86215] human common host

Immunology
malaria Malaria (MeSH) blood and lymphatic disease
parasitic disease

Blood and Lymphatics
Genome
Protozoan

Malaria
Zdroj: Jensen, K, Plichta, D R, Panagiotou, G & Kouskoumvekaki, I 2012, ' Mapping the genome of Plasmodium falciparum on the drug-like chemical space reveals novel anti-malarial targets and potential drug leads ', Molecular BioSystems, vol. 8, no. 6, pp. 1678-1685 . https://doi.org/10.1039/c2mb00008c
ISSN: 1742-2051
DOI: 10.1039/c2mb00008c
Popis: The parasite Plasmodium falciparum is the main agent responsible for malaria. In this study, we exploited a recently published chemical library from GlaxoSmithKline (GSK) that had previously been confirmed to inhibit parasite growth of the wild type (3D7) and the multi-drug resistance (D2d) strains, in order to uncover the weak links in the proteome of the parasite. We predicted 293 proteins of P. falciparum, including the six out of the seven verified targets for P. falciparum malaria treatment, as targets of 4645 GSK active compounds. Furthermore, we prioritized druggable targets, based on a number of factors, such as essentiality for growth, lack of homology with human proteins, and availability of experimental data on ligand activity with a non-human homologue of a parasite protein. We have additionally prioritized predicted ligands based on their polypharmacology profile, with focus on validated essential proteins and the effect of their perturbations on the metabolic network of P. falciparum, as well as indication of drug resistance emergence. Finally, we predict potential off-target effects on the human host with associations to cancer, neurological and dermatological disorders, based on integration of available chemical-protein and protein-protein interaction data. Our work suggests that a large number of the P. falciparum proteome is potentially druggable and could therefore serve as novel drug targets in the fight against malaria. At the same time, prioritized compounds from the GSK library could serve as lead compounds to medicinal chemists for further optimization.
Databáze: OpenAIRE